0001972362-24-000670.txt : 20240513 0001972362-24-000670.hdr.sgml : 20240513 20240513181447 ACCESSION NUMBER: 0001972362-24-000670 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240513 DATE AS OF CHANGE: 20240513 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 770160744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-33093 FILM NUMBER: 24940719 BUSINESS ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-550-7500 MAIL ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Korenberg Matthew E CENTRAL INDEX KEY: 0001649903 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 11119 NORTH TORREY PINES ROAD STREET 2: SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 144 1 primary_doc.xml 144 0001649903 XXXXXXXX LIVE 0000886163 LIGAND PHARMACEUTICALS INC 001-33093 555 HERITAGE DRIVE, SUITE 200 JUPITER FL 33458 858-550-7500 Korenberg Matthew E Officer Common Morgan Stanley Smith Barney LLC Executive Services

200 W Civic Center Dr - 4th Floor Sandy UT 84070

5142 434499.00 18000000 05/13/2024 NASDAQ COMMON 02/15/2019 RESTRICTED STOCK ISSUER N 2338 02/15/2019 COMPENSATION COMMON 02/15/2020 RESTRICTED STOCK ISSUER N 2214 02/15/2020 COMPENSATION COMMON 02/15/2021 RESTRICTED STOCK ISSUER N 590 02/15/2021 COMPENSATION Y 05/13/2024 /s/ Matthew E Korenberg